Atlas Trials

Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)

Clinical trial NCT02060656 · UNKNOWN

Trial details

NCT number
NCT02060656
Sponsor
Royal Marsden NHS Foundation Trust
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-Cell Lymphoma
Start date
2013-09-01
Primary completion
2018-02-01
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.